Second Generation Antipsychotic Use in Pediatrics

Jordan Haygood, PharmD, BCPP - Second Generation Antipsychotic Use in Pediatrics

This presentation will review select FDA approved and off label indications of second generation antipsychotics in patient less 18 years of age, with a focus on dosing, side effects, monitoring, and drug interactions.

Link to Zoom meeting